@entity323 and Sexual Hormone Levels in XXXX With Obstructive Sleep Apnea: Efficacy of Continuous Positive Airway Pressure.

@entity1 @entity323 @entity251 @entity27 @entity53 @entity1871
UNASSIGNED: In this study, the prevalence of @entity323 ( @entity323 ) and serum sexual hormone levels were evaluated in @entity1 with @entity27 ( @entity27 ). In these @entity1 , the efficacy of continuous positive airway pressure (CPAP) was determined. The 207 @entity1 (mean age 44.0      11.1  years) enrolled in the study were stratified within four groups based on their @entity27 index score: simple snoring (n  =  32), mild @entity27 (n  =  29), moderate @entity27 (n  =  38), and severe @entity27 (n  =  108). The International Index of @entity323 -5 (IIEF-5) score was obtained from each @entity1 , and blood samples for the analysis of sexual hormones (prolactin, luteotropin, follicle-stimulating hormone, @entity53 , @entity1871 , and @entity251 ) were drawn in the morning after polysomnography. The IIEF-5 test and serum sexual hormone measurements were repeated after 3  months of CPAP treatment in 53 @entity1 with severe @entity27 . The prevalence of @entity323 was 60.6  % in @entity27 @entity1 overall and 72.2  % in those with severe @entity27 . Compared with the simple snoring group, @entity1 with severe @entity27 had significantly lower @entity251 levels (14.06      5.62 vs. 17.02      4.68, p  =  .018) and lower IIEF-5 scores (16.33      6.50 vs. 24.09      1.94, p  =  .001). The differences in the other sexual hormones between groups were not significant. After 3  months of CPAP treatment, there were no significant changes in sexual hormone levels, but the IIEF-5 score had improved significantly (18.21      4.05 vs. 19.21      3.86, p  =  .001). Severe @entity27 @entity1 have low @entity251 concentration and high @entity323 prevalence. IIEF-5 scores increased significantly after CPAP treatment, but there was no effect on serum @entity251 levels.
